Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma
Translational Research
· Elsevier
Аннотация
Publication date: December 2026 Source: Translational Research, Volume 298 Author(s): Pin-Jie Li, Tzu-Yi Liao, Yen-Ling Liu, Zih-Yu Jhuang, En-Shuo Liu, Bo-Cheng Huang, Shih-Ting Hong, Chia-Ching Lee, Yu-Tung Chen, Chiao-Yun Chen, Fang-Ming Chen, Tian-Lu Cheng, Wen-Wei Lin, Kai-Wen Ho
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Медицинская биохимия»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma. // Translational Research. – URL: https://www.sciencedirect.com/science/article/pii/S1931524426002215?dgcid=rss_sd_all
Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma. Translational Research. https://www.sciencedirect.com/science/article/pii/S1931524426002215?dgcid=rss_sd_all
“Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma.” Translational Research.
@article{article69967,
title = {Bispecific antibody-mediated cell surface accumulation of PEGylated asparaginase enhances therapeutic efficacy and attenuates stromal protection in CD20-positive lymphoma},
journal = {Translational Research},
url = {https://www.sciencedirect.com/science/article/pii/S1931524426002215?dgcid=rss_sd_all}
}